scispace - formally typeset
M

Mikael Lundin

Researcher at University of Helsinki

Publications -  144
Citations -  6572

Mikael Lundin is an academic researcher from University of Helsinki. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 37, co-authored 140 publications receiving 5794 citations. Previous affiliations of Mikael Lundin include Lund University & Karolinska University Hospital.

Papers
More filters
Journal Article

Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.

TL;DR: The results indicate that elevated Cox-2 expression is more common in breast cancers with poor prognostic characteristics and is associated with an unfavorable outcome, and support efforts to initiate clinical trials on the efficacy of Cox- 2 inhibitors in adjuvant treatment of breast cancer.
Journal ArticleDOI

Deep learning based tissue analysis predicts outcome in colorectal cancer

TL;DR: The results suggest that state-of-the-art deep learning techniques can extract more prognostic information from the tissue morphology of colorectal cancer than an experienced human observer.
Posted Content

Physics Performance Report for PANDA: Strong Interaction Studies with Antiprotons

M.F.M. Lutz, +410 more
TL;DR: The PANDA detector as mentioned in this paper is a state-of-the-art internal target detector at the HESR at FAIR allowing the detection and identification of neutral and charged particles generated within the relevant angular and energy range.
Journal ArticleDOI

Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer

TL;DR: A new paradigm for the forkhead protein FoxA1 action in androgen signalling is reported, which was associated with poor prognosis, whereas low FoxA 1 level, even in the presence of high AR expression, predicted good prognosis.